AC
ARRY

Athos Capital’s Array Biopharma Inc ARRY Stock Holding History

Athos Capital’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-112,427
Closed -$5.21M – 42
2019
Q2 		$5.21M Buy
+112,427
New +$3.16M 2.3% 7

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Athos Capital's ARRY Position: Q3 2019 in Review

Athos Capital sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 112,427 shares — an estimated $5.21M sold.

Athos Capital first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $5.21M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Athos Capital reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Athos Capital sold 112,427 Array Biopharma Inc shares in Q3 2019, an estimated $5.21M.
  • Athos Capital first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
  • Athos Capital's Array Biopharma Inc position peaked at $5.21M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Athos Capital's 13F filing for Q3 2019, filed 13 Nov 2019.